RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication Gallery

RareStone’s pitolisant (Wakix) was approved by China NMPA for the treatment of narcolepsy, and became the first approved innovative drug for narcolepsy and the only non-scheduled drug with narcolepsy indication

ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchange Gallery

ScienTech Medical Technology, a Vivo Capital portfolio company, Successfully Lists on the Main Board of Hong Kong Stock Exchange

Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics Gallery

Vivo Capital Invests in Zenas Biopharma’s $118 Million Financing to Advance the Company’s Broad Pipeline of Autoimmune Disease Therapeutics

NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma Gallery

NMPA Approves Suzhou Omni’s Compound Ipratropium Bromide Solution for Inhalation to Treat Symptoms of COPD and Asthma

FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Gallery

FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older

Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China Gallery

Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn Gallery

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn

Legend Biotech Announces FDA Approval of CARVYKTI Gallery

Legend Biotech Announces FDA Approval of CARVYKTI

Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering Gallery

Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering

Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital Gallery

Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market  Gallery

Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market 

Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery

Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)